Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.

Istampoulouoglou, Ioanna; Zimmermanns, Barbara; Grandinetti, Tanja; Marzolini, Catia; Harings-Kaim, Annette; Koechlin-Lemke, Sarah; Scholz, Irene; Bassetti, Stefano; Leuppi-Taegtmeyer, Anne B

Istampoulouoglou, Ioanna; Zimmermanns, Barbara; Grandinetti, Tanja; Marzolini, Catia; Harings-Kaim, Annette; Koechlin-Lemke, Sarah; Scholz, Irene; Bassetti, Stefano; Leuppi-Taegtmeyer, Anne B.

Afiliación

Istampoulouoglou I; Department of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland.
Zimmermanns B; University of Basel, Basel, Switzerland.
Grandinetti T; Department of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland.
Marzolini C; Regional Pharmacovigilance Centre Basel, University Hospital Basel, Switzerland.
Harings-Kaim A; University of Basel, Basel, Switzerland.
Koechlin-Lemke S; Department of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland.
Scholz I; University of Basel, Basel, Switzerland.
Bassetti S; Division of Infectious Diseases & Hospital Hygiene, University Hospital Basel, Switzerland.
Leuppi-Taegtmeyer AB; University of Basel, Basel, Switzerland.

Glob Cardiol Sci Pract ; 2021(2): e202111, 2021 Jun 30.

Article en En | MEDLINE | ID: mdl-34285902

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Glob Cardiol Sci Pract Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Qatar

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google